VerifiedSigned 2026-03-09 · Independent third-party lab
Purity
98.9%
Dose
50mg blend per vial
Produced
2026-03-05
Verified
2026-03-09
HPLC trace · C18 column · 210nm
Primary chromatogram
Secondary verification
Mass spectrometry.
Mass spec confirms the molecular weight of the primary peak matches the expected compound. Expected MW: Multi. Observed MW: Multi (±0.2 Da).
Certificate of analysis
Full specification.
Signed and dated by the independent lab. Every field below is published as received — nothing adjusted, nothing omitted.
Compound
KLOW
Batch ID
PX-2026-0133
CAS Number
Blend
Molecular formula
BPC-157 · TB-500 · GHK-Cu · KPV
Molecular weight
Multi
Dose per vial
50mg blend per vial
Purity (HPLC)
98.9%
Identity (MS)
Confirmed — [M+H]⁺ match
Production date
2026-03-05
Verification date
2026-03-09
Independent lab
Independent third-party lab
Browse other batches
Every batch we’ve documented.
PX-2026-0142
GLP-3 (Retatrutide)
2026-03-28
99.1%
PX-2026-0138
NAD+
2026-03-18
99.0%
PX-2026-0133
KLOW
2026-03-05
98.9%
PX-2026-0134
Semax
2026-03-08
99.1%
PX-2026-0131
Tirzepatide
2026-02-28
99.3%
PX-2026-0130
BPC-157
2026-02-25
99.1%
PX-2026-0129
PT-141 (Bremelanotide)
2026-02-22
99.1%
PX-2026-0127
MT-II (Melanotan II)
2026-02-18
99.0%
PX-2026-0125
Epitalon
2026-02-10
99.2%
PX-2026-0143
Semaglutide
2026-04-04
99.2%
PX-2026-0144
TB-500
2026-04-06
99.0%
PX-2026-0145
Ipamorelin
2026-04-08
99.3%
PX-2026-0146
CJC-1295 (DAC)
2026-04-10
99.2%
PX-2026-0147
GHK-Cu
2026-04-12
99.4%
PX-2026-0148
Selank
2026-04-14
99.1%
PX-2026-0149
MOTS-c
2026-04-16
99.0%
PX-2026-0150
Thymosin Alpha-1
2026-04-18
99.2%
PX-2026-0151
DSIP
2026-04-20
99.1%
PX-2026-0152
AOD-9604
2026-04-22
99.3%
PX-2026-0153
5-Amino-1MQ
2026-04-22
99.5%
PX-2026-0154
Tesamorelin
2026-04-24
99.2%
PX-2026-0155
Kisspeptin-10
2026-04-25
99.2%
PX-2026-0156
Cerebrolysin
2026-04-26
99.0%
PX-2026-0157
HCG
2026-04-27
99.0%